Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases

被引:50
|
作者
Nishiguchi, Gisele A. [1 ]
Atallah, Gordana [1 ]
Bellamacina, Cornelia [1 ]
Burger, Matthew T. [1 ]
Ding, Yu [1 ]
Feucht, Paul H. [2 ]
Garcia, Pablo D. [2 ]
Han, Wooseok [1 ]
Klivansky, Liana [1 ,2 ,3 ]
Lindvall, Mika [1 ]
机构
[1] Novartis Inst BioMed Res, Global Discovery Chem Oncol & Exploratory Chem, Emeryville, CA 94608 USA
[2] Novartis Inst BioMed Res, Oncol Res, Emeryville, CA 94608 USA
[3] Univ Calif Berkeley, Lawrence Berkeley Lab, Mol Foundry, Berkeley, CA 94720 USA
关键词
Pim-kinase inhibitors; Indole; Kinase selectivity; Oncology; PROTOONCOGENE PIM-1; BINDING MODE; CELL; CANCER; PROGRESSION; TUMORIGENESIS; EXPRESSION; APOPTOSIS; LYMPHOMA; SURVIVAL;
D O I
10.1016/j.bmcl.2011.08.105
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel 3,5-disubstituted indole derivatives as potent and selective inhibitors of all three members of the Pim kinase family is described. High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold. Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compounds against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC(50) <= 2 nM and Pim-2: IC(50) <= 100 nM). (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6366 / 6369
页数:4
相关论文
共 50 条
  • [1] Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases
    Dakin, Les A.
    Block, Michael H.
    Chen, Huawei
    Code, Erin
    Dowling, James E.
    Feng, Xiaomei
    Ferguson, Andrew D.
    Green, Isabelle
    Hird, Alexander W.
    Howard, Tina
    Keeton, Erika K.
    Lamb, Michelle L.
    Lyne, Paul D.
    Pollard, Hannah
    Read, Jon
    Wu, Allan J.
    Zhang, Tao
    Zheng, Xiaolan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4599 - 4604
  • [2] Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
    Xia, Zuping
    Knaak, Christian
    Ma, Jian
    Beharry, Zanna M.
    McInnes, Campbell
    Wang, Wenxue
    Kraft, Andrew S.
    Smith, Charles D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (01) : 74 - 86
  • [3] Discovery and evaluation of 3,5-disubstituted indole derivatives as Pim kinase inhibitors
    More, Kunal N.
    Hong, Victor S.
    Lee, Ahyeon
    Park, Jongsung
    Kim, Shin
    Lee, Jinho
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (14) : 2513 - 2517
  • [4] Comparison between knockdown of Pim-1, Pim-2 and Pim-3 identifies Pim-2 as the most relevant Pim oncogene in hepatocellular carcinoma
    Weirauch, Ulrike
    Kurz, Pia
    Aigner, Achim M.
    CANCER RESEARCH, 2017, 77
  • [5] Who is most important? Comparison between knockdown of Pim-1, Pim-2 and Pim-3 identifies Pim-2 as the most relevant Pim oncogene in hepatocellular carcinoma
    Weirauch, U.
    Kuerz, P.
    Aigner, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S64 - S64
  • [6] 3D-QSAR and Pharmacophore modeling of 3,5-disubstituted indole derivatives as Pim kinase inhibitors
    Varpe, Bhushan D.
    Jadhav, Shailaja B.
    Chatale, Bandoo C.
    Mali, Anil S.
    Jadhav, Shravan Y.
    Kulkarni, Amol A.
    STRUCTURAL CHEMISTRY, 2020, 31 (05) : 1675 - 1690
  • [7] 3D-QSAR and Pharmacophore modeling of 3,5-disubstituted indole derivatives as Pim kinase inhibitors
    Bhushan D. Varpe
    Shailaja B. Jadhav
    Bandoo C. Chatale
    Anil S. Mali
    Shravan Y. Jadhav
    Amol A. Kulkarni
    Structural Chemistry, 2020, 31 : 1675 - 1690
  • [8] Discovery of novel Pim-1 inhibitors
    Xiang, Yibin
    Hirth, Bradforth H.
    Liu, Jinyu
    Metz, Markus
    Asmussen, Gary
    Bieman, Hans-Peter N.
    Fitzgerald, Maria
    Fremgen, Trish
    Jancsics, Katherine C.
    Kothe, Michael
    Papoulis, Andrew T.
    Stepp, David J.
    Wei, Ronnie
    Skerlj, Renato
    CANCER RESEARCH, 2011, 71
  • [9] Structural insights for rational design of new PIM-1 kinase inhibitors based on 3,5-disubstituted indole derivatives: An integrative computational approach
    Razmazma, Hafez
    Ebrahimi, Ali
    Hashemi, Mohammad
    COMPUTERS IN BIOLOGY AND MEDICINE, 2020, 118
  • [10] Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors
    Wurz, Ryan P.
    Sastri, Christine
    D'Amico, Derin C.
    Herberich, Brad
    Jackson, Claire L. M.
    Pettus, Liping H.
    Tasker, Andrew S.
    Wu, Bin
    Guerrero, Nadia
    Lipford, J. Russell
    Winston, Jeffrey T.
    Yang, Yajing
    Wang, Paul
    Nguyen, Yen
    Andrews, Kristin L.
    Huang, Xin
    Lee, Matthew R.
    Mohr, Christopher
    Zhang, J. D.
    Reid, Darren L.
    Xu, Yang
    Zhou, Yihong
    Wang, Hui-Ling
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (22) : 5580 - 5590